When did DOC ever say that the China and India deals were give aways because they weren't worth much? That sounds like a supposition. They are huge markets, regardless of the reimbursement rates, and if EMA approval were to lead to approval in those countries it would be worth alot of market cap. The more logical reason for those deals was that ADXS didn't have the money to fund trials at that point. ADXS was not exactly in a position of power.